1. Main page
  2. Biotechnology
  3. Insulet

Insulet

4 Decision Makers · 5 Verified Contacts & Email Format

omnipod.com
📍 Bedford, Massachusetts, United StatesBiotechnology🗓 Est. 2000👥 501–1000 employees

About Insulet

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System.

Email Format

{first_name}.{last_name}@omnipod.com — 100.0%

sarah.smith@omnipod.com

Leadership & Decision Makers

Contact details of 4 Insulet decision makers

Annette Ballou

Senior Director, Strategic Alliances

Bret Christensen

Chief Commercial Officer

Charles Liamos

Chief Operating Officer

Patrick Sullivan

President & CEO

Team & Specialists

Contact details of 1 Insulet team members

Greg Davis

  • Work email

    g********s@omnipod.com

General Emails

General company emails, e.g. customer support lines

    international@insulet.com

    Unclassified inbox

    gwen@omnipod.com

    Unclassified inbox

    greg.davis@omnipod.com

    Unclassified inbox

    cordova@omnipod.com

    Unclassified inbox

Verify Insulet Emails

Similar Companies like Insulet

Bio-Techne

bio-techne.com
Biotechnology · Minneapolis, MN · Est. 1981 · 1001–5000 employees

HQ: Minneapolis, MN

Edwards Lifesciences

edwards.com
Biotechnology · Irvine, CA · Est. 1958 · 5001–10000 employees

HQ: Irvine, CA

Medtronic

medtronic.com
Biotechnology · Minneapolis, MN · Est. 1949 · Above 10001 employees

HQ: Minneapolis, MN

Tempus

tempus.com
AI & Machine Learning · Chicago, IL · Est. 2015 · 501–1000 employees · $500M–$1B

HQ: Chicago, IL

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 31/07/2025

omnipod.com

7814575100

Bedford, Massachusetts, United States

Specialization: Diabetes,
Legal Name: Insulet Corporation
Business Type: Private
Employees: 501-1000
Rounds: Post-IPO Debt
Founded Date: 2000
Company Type: For Profit
Operating Status: Active
Last Funding Type: Post-IPO Debt
Phone Number: 7814575100
Sub-Organization of: Insulet
Last Investment Activity: Mar 8, 2024
Investments Activity: Mar 8, 2024 May 4, 2023 Apr 17, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.